High prevalence of fluoroquinolone-resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018–2020,Academic Emergency Medicine

当前位置： X-MOL 学术 › Acad. Emerg. Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

High prevalence of fluoroquinolone-resistant UTI among US emergency department patients diagnosed with urinary tract infection, 2018–2020
Academic Emergency Medicine ( IF 3.4 ) Pub Date : 2022-06-02 , DOI: 10.1111/acem.14545
Brett A. Faine ₁ , Megan A. Rech ₂ , Priyanka Vakkalanka ₃ , Alan Gross ₄ , Caitlin Brown ₅ , Stephanie J. Harding ₆ , Giles Slocum ₇ , David Zimmerman ₈ , Anne Zepeski ₉ , Stacey Rewitzer ₁₀ , Gavin T. Howington ₁₁ , Matt Campbell ₁₂ , Jordan Dawson ₁₃ , Cierra N. Treu ₁₄ , Lucas Nelson ₁₅ , Mandy Jones ₁₆ , Tara Flack ₁₇ , Blake Porter ₁₈ , Preeyaporn Sarangarm ₁₉ , Alicia E. Mattson ₂₀ , Abby Bailey ₂₁ , Gregory Kelly ₂₂ , David A. Talan ₂₃

Affiliation

Department of Emergency Medicine and Pharmacy University of Iowa Hospitals and Clinics Hawkins IA USA
Emergency Medicine Clinical Pharmacist, Affiliate Assistant Professor, Department of Emergency Medicine Loyola University Medical Center
Assistant Research Scientist, Department of Emergency Medicine University of Iowa
Infectious Diseases Pharmacist, Clinical Associate Professor University of Illinois at Chicago College of Pharmacy
Assistant Professor of Pharmacy and Emergency Medicine Mayo Clinic School of Medicine and Science Rochester MN USA
Infectious Diseases Clinical Pharmacy Specialist Wesley Medical Center
Emergency Medicine Clinical Pharmacy Specialist, Department of Pharmacy and Emergency Medicine Rush University Medical Center
Associate Professor of Pharmacy at Duquesne University School of Pharmacy Emergency Medicine Pharmacist at University of Pittsburgh Medical Center‐ Mercy Hospital
Emergency Medicine Clinical Pharmacist University of Iowa
Clinical Pharmacist, Methodist Hospital St. Louis Park MN USA
Department of Pharmacy Practice and Science University of Kentucky College of Pharmacy Emergency Medicine Clinical Pharmacy Specialist
Emergency Medicine Clinical Pharmacist, Emergency Medicine Clinical Coordinator, Department of Pharmacy, Cleveland Clinic
Acute Care Pharmacy Clinical Supervisor, Emergency Medicine and Critical Care, Denver Health Medical Center
Clinical Pharmacy Coordinator, Emergency Medicine New York‐Presbyterian Brooklyn Methodist Hospital
Emergency Center Pharmacist Lead, Park Nicollet, Methodist Hospital
Clinical Associate Professor College of Pharmacy Emergency Medicine Clinical Pharmacy Specialist, UK HealthCare, Fellow, Center for Interprofessional Healthcare Education, University of Kentucky
Emergency Medicine Clinical Pharmacist Indiana University Health Methodist Hospital
Emergency Medicine Pharmacist Clinician University of Vermont Medical Center Burlington VT USA
ED/ICU Pharmacy Supervisor University of New Mexico Hospital
Emergency Medicine Clinical Pharmacist, Instructor of Pharmacy, Mayo Clinic Rochester MN USA
Clinical Coordinator Emergency Medicine University of Kentucky HealthCare
Clinical Assistant Professor of Pharmacy, Rutgers Ernest Mario College of Pharmacy, Emergency Medicine Clinical Pharmacy Specialist Robert Wood Johnson University Hospital‐ New Brunswick
Professor of Medicine in Residence The David Geffen School of Medicine at UCLA Chairman Emeritus, Dept. of Emergency Medicine, Faculty, Division of Infectious Diseases, Olive View‐UCLA Medical Center

Uropathogen resistance, fluoroquinolone-resistance (FQR), and extended spectrum beta-lactamase (ESBL), has been observed to be emerging worldwide with prevalences above recommended thresholds for routine empirical treatment. The primary aim of our study was to determine the prevalence of FQR from a geographically diverse sample of United States emergency departments (EDs).

中文翻译：

2018-2020 年美国急诊科诊断为尿路感染的患者中耐氟喹诺酮类尿路感染的高患病率

已观察到尿路病原体耐药、氟喹诺酮耐药 (FQR) 和超广谱 β-内酰胺酶 (ESBL) 正在世界范围内出现，其流行率高于常规经验性治疗的推荐阈值。我们研究的主要目的是从美国急诊科 (EDs) 的地理多样化样本中确定 FQR 的患病率。

更新日期：2022-06-02

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11